2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,380

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,544

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,234

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,116

Advances in genetic diagnosis and therapy of hereditary heart disease: a bibliometric review from 2004 to 2024

Ma, H., Wang, Y., Jia, Y., Xie, L., Liu, L., Zhang, D., Ma, X., Guo, Y., & Xu, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1507313 · Cited by 2

Variant sub-tiering, disease-gene associations and strictness of clinical criteria improves the interpretation of variants of uncertain significance in hereditary cardiomyopathies and rhythm disorders

Castori, M., Mastroianno, S., Fontana, A., Morlino, S., Nardella, G., Muro, E. D., Palumbo, P., Leone, M. P., Pracella, R., Palumbo, O., et al. (2025) · Journal of Human Genetics · doi:10.1038/s10038-025-01344-y · Cited by 2

Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging for non-sustained ventricular tachycardia and sudden cardiac death in hypertrophic cardiomyopathy: a meta-analysis

Siddiqi, A. K., Maniya, M. T., Bilen, O., Abdou, M. A. H., Cecco, C. N. D., & Naeem, M. (2025) · European Radiology · doi:10.1007/s00330-025-11961-y · Cited by 2

CRLF1 Secreted by Cardiac Fibroblasts Promotes Human Hypertrophic Cardiomyopathy

Lin, B., Wang, J., Li, C., Wang, S., Shen, M., Hu, L., Chen, L., Zhou, F., Liu, Y., Yang, J. P., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.075290 · Cited by 2

Combined Fixed and Dynamic Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Due to a Coexisting Subaortic Membrane: A Case Report

Zambrano-Cevallos, K. M., Fuentes, S. D. Z., Cárdenas, L., Guerrero, L. M., Garcia, A., Jaramillo-Merino, J., Gavilánez-Zambrano, S., Rojas-Cadena, M., & Izquierdo‐Condoy, J. S. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083115 · Cited by 2

Ventricular arrhythmia management in patients with genetic cardiomyopathies

Sharif, Z. I., & Lubitz, S. A. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.10.009 · Cited by 2

Preemptive alcohol septal ablation prior to transcatheter mitral valve replacement

Wong, N., Lim, D. S., Yount, K. W., Yarboro, L. T., Ailawadi, G., & Ragosta, M. (2023) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30879 · Cited by 2

Transaortic septal myectomy at the time of aortic valve replacement for severe aortic stenosis: a case series of 55 cases

Karapanagiotidis, G. T., Anastasakis, E., Nana, C., Gukop, P. S., Zakkar, M., Tossios, P., Grosomanidis, V., Sarridou, D. G., Krimiotis, D., & Sarsam, M. A. I. (2023) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-023-01661-x · Cited by 2

Radiofrequency Catheter Septal Ablation via a Trans-Atrial Septal Approach Guided by Intracardiac Echocardiography in Hypertrophic Obstructive Cardiomyopathy: One-Year Follow-Up

Li, X., Liu, T., Cui, B., Chen, Y., Tang, C., & Wu, G. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2502038 · Cited by 2

Machine Learning-Driven Diagnostic Signature Provides New Insights in Clinical Management of Hypertrophic Cardiomyopathy

Liu, S., Yuan, P., Zheng, Y., Guo, C., Ren, Y., Weng, S., Zhang, Y., Liu, L., Xing, Z., Wang, L., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14762 · Cited by 2

Myocardial hypertrophy: the differentiation of uremic, hypertensive, and hypertrophic cardiomyopathies by cardiac MRI

Tian, Z., Jin, S., Huo, H., Zheng, Y., Li, Y., Liu, H., Geng, Z., Liu, S., Li, S., Liu, Z., et al. (2024) · Insights into Imaging · doi:10.1186/s13244-024-01770-0 · Cited by 2

Safety and Effectiveness of Mavacamten Use in Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis

Alharbi, T. Y., Alnadawi, H. A., Almutairi, G. M., Altheyab, F. Y., Aldoweesh, O. H., Alfehaid, O. S., Alhaj, A. A., Alotaibi, A. M., & Zweihary, A. M. A. (2024) · Cureus · doi:10.7759/cureus.70550 · Cited by 2

Recurrent atrial flutter after radiofrequency ablation for atrial fibrillation in a patient with hypertrophic obstructive cardiomyopathy undergoing repetitive transcoronary ablation of septal hypertrophy

Cheng, L., Wang, N., Dai, L., Ding, H., Geng, Z., & Son, Y. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04135-z · Cited by 2

Supraventricular ectopic activity predicts postoperative atrial fibrillation, new-onset atrial fibrillation, and worse survival in obstructive hypertrophic cardiomyopathy

Nie, C., Zhu, C., Xiao, M., Wu, Z., Yang, Q., Lu, Z., Lü, T., Meng, Y., & Wang, S. (2024) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae101 · Cited by 2

Perioperative Outcomes for Children With Cardiomyopathy Undergoing Noncardiac Procedures

Liu, J., Przybylski, R., Mari, M. J., Foz, C., Kobayashi, R., Abrams, D. J., & Nasr, V. G. (2025) · Pediatric Anesthesia · doi:10.1111/pan.15120 · Cited by 2

Variation p.R1045H in MYH7 correlated with hypertrophic cardiomyopathy in a Chinese pedigree

Zhang, Y., Shang, Y., Liu, L., Ding, X., Wu, H., Li, L., & Pang, M. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01046-2 · Cited by 2

Novel Myosin-Based Therapies in Hypertrophic Cardiomyopathy

Sewanan, L. R., & Jacoby, D. L. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00921-6 · Cited by 2

The 2020 American Heart Association / American College of Cardiology guidelines for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: What is new?

Budagaev, S. A., Afanasyev, A. V., Bogachev-Prokophiev, A. V., Сергеевич, З. А., & Ovcharov, M. A. (2021) · Patologiya krovoobrashcheniya i kardiokhirurgiya · doi:10.21688/1681-3472-2021-2-108-115 · Cited by 2

Comparison of mitral regurgitation severity assessments based on magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy

Śpiewak, M., Kłopotowski, M. M., Kowalik, E., Mazurkiewicz, Ł., Kożuch, K., Petryka, J., Miłosz‐Wieczorek, B., Witkowski, A., Klisiewicz, A., & Marczak, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-99446-y · Cited by 2

Short-term outcomes of surgical atrial ablation and septal myectomy

Сергеевич, З. А., Bogachev-Prokophiev, A. V., Afanasyev, A. V., Махарамович, Ш. Р., Sapegin, A. V., Budagaev, S. A., Иванович, Ж. С., & Иванович, Д. И. (2021) · Patologiya krovoobrashcheniya i kardiokhirurgiya · doi:10.21688/1681-3472-2021-3-51-60 · Cited by 2

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator

Kłopotowski, M. M., Kukuła, K., Jamiołkowski, J., Oręziak, A., Dąbrowski, M., Chmielak, Z., & Witkowski, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061633 · Cited by 2

A Morte Súbita Cardíaca em Atletas e a Avaliação Médico-Desportiva Cardiovascular em Portugal

Sousa, J. M., & Abreu, A. (2022) · Revista de Medicina Desportiva informa · doi:10.23911/emd_morte_subita_2022_jul · Cited by 2

ARRHYTHMIC SUDDEN DEATH SURVIVAL PREDICTION MODEL FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS: AN INTERPRETABLE MACHINE LEARNING ANALYSIS

Farahani, N. Z., Enayati, M., Pumarejo, A., Aguirre, M. A., Scott, C. G., Siontis, K. C., Bos, M., Geske, J. B., Ackerman, M. J., & Arruda-Olson, A. M. (2023) · Design of Medical Devices Conference (DMD) · doi:10.1115/dmd2023-2989 · Cited by 2

Avaliação Prognóstica da Microalternância da onda T na Cardiomiopatia Hipertrófica em um Seguimento Clínico de 9 anos

Antunes, M. D. O., Arteaga-Fernández, E., Samesima, N., Pereira, H. G., Matsumoto, A. Y., Verrier, R. L., Pastore, C. A., & Mady, C. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220833 · Cited by 2

Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning)

Estes, N. A. M., & Wong, T. C. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019876 · Cited by 2

The next step in deep learning-guided clinical trials

Krittanawong, C. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00044-6 · Cited by 2

Behind Enemy Lines: Vital Echocardiographic Data Prior to Ventricular Arrhythmia Ablation

Deaconu, S., Deaconu, A. I., Marascu, G., Petre, I. G., & Vatasescu, R. G. (2022) · Diagnostics · doi:10.3390/diagnostics12092109 · Cited by 1

Clinical Usage of Cardiovascular Magnetic Resonance Imaging: Single-Center Experience in the New Era of Cardiovascular Imaging

Tok, Ö. Ö., Tokdil, H., Tokdil, K. O., Sevgican, C. İ., & Bingöl, G. (2022) · Istanbul Medical Journal · doi:10.4274/imj.galenos.2022.90757 · Cited by 1

A Young Pregnant Person With Old Myocardial Infarction

Wang, L., Zhang, M., & Jing, J. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.5251 · Cited by 1

Features of left ventricular outflow obstruction in patients with different phenotypes of hypertrophic cardiomyopathy

Игнатенко, Г. А., Тарадин, Г. Г., Евгеньевна, К. Т., & Kulikova, S. O. (2024) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio2024170117 · Cited by 1

Hypersynchrony in sarcomeric hypertrophic cardiomyopathy: description and mechanistic approach using multimodal electro-mechanical non-invasive cartography (HSYNC study)

Réant, P., Bonnet, G., Dubé, F., Massie, C., Reynaud, A. J., Michaud, M., Duchâteau, J., & Lafitte, S. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1359657 · Cited by 1

Redefining Management in Hypertrophic Cardiomyopathy: The Role and Challenges of Exercise Rehabilitation

Verma, A., Anand, A., Patel, V. A., Singh, A., Ahsan, A., Kanagala, S. G., Jain, H., Dey, R. C., Khatib, M. N., Zahiruddin, Q. S., et al. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000766 · Cited by 1

Cardiac hypertrophy in polycythemia vera: A case report and review of literature

Ma, B.-S., Zhai, S.-H., Chen, W., & Zhao, Q.-N. (2024) · World Journal of Cardiology · doi:10.4330/wjc.v16.i11.651 · Cited by 1

Exome sequencing data reanalysis of 200 hypertrophic cardiomyopathy patients: the HYPERGEN French cohort 5 years after the initial analysis

Jaouadi, H., Morel, V., Martel, H., Lindenbaum, P., de la Chapelle, L. L., Herbane, M., Lucas, C. H., Magdinier, F., Habib, G., Schott, J., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1480947 · Cited by 1

Causal relationship between leukocyte telomere length and two cardiomyopathies based on a bidirectional Mendelian randomization approach

Li, J., Hu, L., & Huang, X. (2024) · Medicine · doi:10.1097/md.0000000000040308 · Cited by 1

Predictive value of cardiopulmonary exercise test parameters for atrial fibrillation risk in hypertrophic cardiomyopathy patients

Wang, L. (2025) · American Journal of Translational Research · doi:10.62347/keno8599 · Cited by 1

Unraveling the genetics of feline hypertrophic cardiomyopathy: a multiomics study of 138 cats

Kaplan, J. L., Rivas, V. N., Vandewege, M. W., Wouters, J. R., Harris, S. P., Meurs, K. M., & Stern, J. A. (2025) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkaf153 · Cited by 1

Development and validation of an echocardiographic nomogram for identifying cardiac amyloidosis in patients with left ventricular hypertrophy

Liang, S., Liu, Z., Shi, F., Chen, L., Li, D., Peng, Y., He, W., Du, C., & Huang, H. F. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04973-5 · Cited by 1

Apical Hypertrophic Cardiomyopathy: A Rare and Hidden Cause of Stroke

Stringer, I., Patel, A., Edhem, L., Delamere, R., Eni, G., Ahmed, A., & Solano, J. (2025) · Cureus · doi:10.7759/cureus.96681 · Cited by 1

Genetic diversity and molecular mechanisms in hypertrophic cardiomyopathy: toward personalized therapy

Marwaha, K., Mody, B. P., Holland, N. A., Lane, M., Shoemake, B. D., Singh, N., & Mody, F. V. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00500.2025 · Cited by 1

Comprehensive Assessment of Left Ventricular Function and Exercise Endurance in Patients with Hypertrophic Cardiomyopathy: The Combined Application of Left Ventricular Pressure-Strain Loop and Cardiopulmonary Exercise Testing

Lin, Y., Hou, S., Lin, J., Zhang, T., Wu, B., Wu, Q., Qiu, S., Chen, J., Chen, D., & Huang, J. (2026) · Cardiology · doi:10.1159/000550829 · Cited by 1

The triglyceride-glucose index is inversely associated with atrial fibrillation in patients with hypertrophic cardiomyopathy: evidence from a cross-sectional study

Wang, S., Zhang, K., Ren, C., Zhang, X., Cui, H., & Lai, Y. (2026) · European journal of medical research · doi:10.1186/s40001-026-04035-2 · Cited by 1

Yamaguchi Syndrome: A Case of Apical Hypertrophic Cardiomyopathy in a Patient From West Africa

Dzebu, A. S., & Awini, D. (2026) · Cureus · doi:10.7759/cureus.103543 · Cited by 1

Application of untargeted plasma metabolomics and machine learning to construct a diagnostic model for hypertrophic cardiomyopathy: a case-control study

Li, R., Wang, B., Shan, B., Sun, M., Ta, S., Zhao, J., Kang, N., Yang, F., Yuan, Y., Li, X., et al. (2026) · Metabolomics · doi:10.1007/s11306-026-02412-w · Cited by 1

Safety and efficacy of physical activity in hypertrophic cardiomyopathy patients: a systematic review and metanalysis

Borrelli, F., Tarditi, F., Andreis, A., Mabritto, B. M. T., Benso, A. S., & Toso, E. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1739956 · Cited by 1

Comparing Cardiac Genetic Testing Pathways: Impacts on Access, Informed Choice, and Decisional Satisfaction

Christian, S., Belcher, T. C., Benoit, M., Chan, A., Dzwiniel, T., İlhan, E., Jain, S., Katchmer, K., Kiamanesh, O., Lilley, M., et al. (2026) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.126.005829 · Cited by 1

Pediatric heart failure in the era of cardio-immunology: inflammatory–immune context phenotypes, diagnosis, and targeted management

Li, D., & Yao, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1776897 · Cited by 1

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy

Lewis, G. D., García‐Pavía, P., Masri, A., Merkely, B. P., Nassif, M. E., Pena-Pena, M. L., Barriales-Villa, R., Bilen, O., Peña, M. S. B., Claggett, B. L., et al. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.1730 · Cited by 1

Cardiomyopathy Etiologies, Symptoms and Management

Kian, W., Zemel, M., Kestenbaum, E. H., Alguayn, W., Shvarts, B., Sharb, A. A., Levitas, D., Kian, Y., Peled, N., & Yakobson, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95566 · Cited by 1

Wet lung in hypertrophic cardiomyopathy: another step towards comprehensive stress echocardiography

Cotrim, C. (2022) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-022-02636-6 · Cited by 1

Surgical treatment of obstructive hypertrophic cardiomyopathy in children with Noonan syndrome

Gandaeva, L. A., Basargina, E. N., Kondakova, O. B., & Savostyanov, K. V. (2022) · Russian Pediatric Journal · doi:10.46563/1560-9561-2022-25-2-96-105 · Cited by 1

My Approach to Echocardiography in Radiofrequency Ablation of Hypertrophic Obstructive Cardiomyopathy

de Cardiologia, I. D. P., Paladino, A. T., Vilela, A. D. A., de Cardiologia, I. D. P., FLEURY, G., Assef, J. E., de Cardiologia, I. D. P., Valdigem, B. P., & de Cardiologia, I. D. P. (2022) · ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR · doi:10.47593/2675-312x/20223502ecom28 · Cited by 1

Percutaneous transluminal septal myocardial ablation was effective in hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles: a case report

Yuzawa-Tsukada, N., Tokuda, M., Miyamoto, T., & Yoshimura, M. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac493 · Cited by 1

Triple Threat: Significant Concomitant Aortic Stenosis, Mitral Stenosis, and Systolic Anterior Motion of the Mitral Valve Causing Left Ventricular Outflow Tract Obstruction in Cardiac Surgical Patients

Glines, K., Hayanga, J. W. A., Gibson, C., Churafa, M. E., Wei, L. M., & Hayanga, H. K. (2023) · Case Reports in Anesthesiology · doi:10.1155/2023/9995115 · Cited by 1

A primer prevenciós ICD-indikációk változása az ESC 2022-es kamrai aritmiák kezelése és hirtelen szívhalál megelőzése szakmai irányvonalban

Makai, A., & Sághy, L. (2023) · Cardiologia Hungarica · doi:10.26430/chungarica.2023.53.4.375 · Cited by 1

Patient experiences in receiving telegenetics care for inherited cardiovascular diseases

Temares, D. S., Liang, L. W., Bergner, A. L., Reilly, M. P., & Kalia, I. (2023) · Journal of Community Genetics · doi:10.1007/s12687-023-00693-5 · Cited by 1

Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification

Alajmi, F., Kang, M., Dundas, J., Haenel, A., Parker, J., Blanke, P., Coghlan, F., Khoo, J. K., Binzaid, A. A., Singh, A., et al. (2024) · Life · doi:10.3390/life14020200 · Cited by 1

Lifestyle Intervention Improves Parasympathetic Activity in Hypertrophic Cardiomyopathy

Alyahya, A. I., Charman, S. J., Okwose, N. C., Fuller, A. S., Eggett, C. J., Luke, P., Bailey, K. M., MacGowan, G. A., & Jakovljević, D. G. (2024) · American Journal of Lifestyle Medicine · doi:10.1177/15598276241253187 · Cited by 1

Perfil epidemiológico de Morbidade Hospitalar por Insuficiência Cardíaca, entre 2019 e 2023: Estudo Ecológico

Costa, I. G. M., Elias, G. M., Silva, C. C. D. P. D. D., Leal, M. P. B. H., Carneiro, A. M., Costa, J. R. N., Cardozo, V. M. A., Oliveira, R. T. C. D., Simplicio, G. D., Santos, K. K. S., et al. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n7p2959-2973 · Cited by 1

Stress echocardiography in daily clinical practice: an update from the European Association of Cardiovascular Imaging

Loria, F., & Luliano, G. (2024) · Heart Vessels and Transplantation · doi:10.24969/hvt.2024.500 · Cited by 1

It has been 30 years since the first alcohol septal ablation for hypertrophic obstructive cardiomyopathy was performed

Veselka, J. (2024) · Swiss Medical Weekly · doi:10.57187/s.3891 · Cited by 1

From Editor-in-Chief: Concluding year 2020, struck by pandemics, a glimpse of hope to end it, many we need to thank; important news, our performance and few words on subordination

Kudaiberdieva, G. (2020) · Heart Vessels and Transplantation · doi:10.24969/hvt.2020.231

Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Diagnosis, Clinical Course and Therapy

Lazzeroni, D., & Centorbi, C. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97033

The Role of Genetics in Cardiomyopaties: A Review

Vernengo, L., & Topaloğlu, H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97242

Dilated phase of hypertrophic cardiomyopathy: high-risk reconstructive surgery as an alternative to heart transplantation

Sl, D., Павловна, М. А., Kalmykova, O. V., Martyanova, Y. B., Тарасов, Д. Г., Dombrovskaya, A. V., & Zaklyazminskaya, E. V. (2021) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202106231

Assesment of Markers of Endothelial Dysfunction and Myocardial Stress in Patients with Hypertrophic Cardyomyopathy

Bogatyreva, F. M., Kaplunova, V. Y., Kozhevnikova, M. V., Андрониковна, Ш. Г., Yatsenko, D. A., Emelianov, А. V., Лишута, А. С., Khabarova, N. V., Privalova, E. V., & Belenkov, Y. N. (2021) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2021-06-06

Relation of Mitral Leaflet Elongation to Nonsustained Ventricular Tachycardia in Patients with Obstructive Hypertrophic Cardiomyopathy

Song, C., Zhang, Y., Zheng, X., Lu, J., Fang, X., Wang, S., & Huang, X. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.07.025

Dynamic Left Ventricular Outflow Tract Obstruction–when to Intervenе?

Mancheva, M., Kostovski, L., Radovikj, M. G., Siljanovski, N., Jovev, S., & Srbinovska, E. (2021) · International Journal of Medical Science and Health Research · doi:10.51505/ijmshr.2021.5611

Considerations for managed care pharmacy in evaluating mavacamten, a novel agent for obstructive hypertrophic cardiomyopathy

Taddei-Allen, P. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.28.3.376

Editorial: Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of Risk

Lopes, L. R., Quarta, G., Cardim, N. M., & Gimeno, J. R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.849882

Comparison of Nonclassic and Classic Phenotype of Hypertrophic Cardiomyopathy Focused on Prognostic Cardiac Magnetic Resonance Parameters: A Single-Center Observational Study

Stachera, M., Przybyło, P., Sznajder, K., & Gierlotka, M. J. (2022) · Diagnostics · doi:10.3390/diagnostics12051104

Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case

Zainetdinov, M. R., Mukharyamov, M., Dzhordzhikiya, R. K., Ильгизович, В. И., Miroshnichenko, M. A., ABDULYANOV, I. V., khaMzin, R. R., Abdulganieva, D. I., Dyakova, E. V., BAYALIEVA, A. Z., et al. (2022) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2022-2-58-64

Mitral valve remodeling in the development of obstructive hypertrophic cardiomyopathy

Moroni, F., Chaturvedi, A., Jafree, E., & Gertz, Z. M. (2023) · Indian Heart Journal · doi:10.1016/j.ihj.2023.06.007

Myocardial Work Combined with a Cardiopulmonary Exercise Test is a Useful Prognostic Assessment of Patients with Non-obstructive HypertrophicPreprint

Lin, Y., Hou, S., Lin, J., Zhang, T., Wu, B., Qiu, S., Chen, J., Chen, D., & Huang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3152957/v1

Myocardial Work Combined with a Cardiopulmonary Exercise Test is a Useful Prognostic Assessment of Patients with Non-obstructive Hypertrophic CardiomyopathyPreprint

Lin, Y., Hou, S., Lin, J., Zhang, T., Wu, B., Qiu, S., Chen, J., Chen, D., & Huang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3126500/v1

Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy

Budagaev, S. A., Zhakayev, M., Tuleutayev, R., Vorontsov, M., Nikitenko, A., Нурбайкызы, Н. Ж., Kunapianov, D., & Pashimov, M. (2023) · Heart Vessels and Transplantation · doi:10.24969/hvt.2023.403

Editorial: Comprehensive risk prediction in cardiomyopathies: new genetic and imaging markers of risk, volume II

Cardim, N. M., Lopes, L. R., & Quarta, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1282587

Severe unprovoked hypertrophic obstructive cardiomyopathy: anaesthetic concerns in patient undergoing parathyroidectomy

Tyagi, A., Nigam, C., Pangtey, R., & Agrawal, V. (2023) · BMJ Case Reports · doi:10.1136/bcr-2023-254641

Quantitative Assessment of Three-Dimensional Aorto-Mitral Angle in Hypertrophic Cardiomyopathy

Garijo, J. M., Gadotti, G., Amador, Y., Fan, C. S., Silverton, N. A., Ralph-Edwards, A. C., & Meineri, M. (2023) · Annals of Thoracic Surgery Short Reports · doi:10.1016/j.atssr.2023.09.016

Ultrasound study of right ventricular myocardial perfusion and functional changes in hypertrophic cardiomyopathy

Cao, S., Yang, L., Liu, L., Mu, Y., & Guan, L. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03705-5

Machine Learning Models identify Signature Genes as potential Biomarkers for Hypertrophic Cardiomyopathy from Williams SyndromePreprint

Yu, H., Liu, X., Sun, M., Li, T., & Nie, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-3924392/v1

Fever Unveiling a Hidden Cardiac Condition: A Case of Pediatric Hypertrophic Obstructive Cardiomyopathy

Reddy, S., Varma, A., & Taksande, A. M. (2024) · Cureus · doi:10.7759/cureus.55823

TERAPIA DE REDUÇÃO SEPTAL NA MIOCARDIOPATIA HIPERTRÓFICA

DORIA, L. P., ZUBEN, P. R. G. D. S. V., YAMASAKI, M. L. P., NETO, G. G., TASHIKAWA, E. A., & GONZALES, B. R. (2024) · doi:10.59290/978-65-6029-097-6.13

Women in Cardiovascular Genetics and Systems Medicine

(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4796-0

Novas terapias para cardiomiopatia hipertrófica: uma revisão integrativa

Heimbeck, H. F., Potratz, M. O., Lani, V. S., & Carneiro, S. D. S. (2024) · Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research · doi:10.47456/rbps.v26isupl_1.44403

Alcohol Septal Ablation for Hypertrophic Cardiomyopathy Guided by Intracoronary Myocardial Contrast Echocardiography to Reduce Myocardial Damage

Chien, S.-F., & Chin, C. (2023) · Journal of Medical Ultrasound · doi:10.4103/jmu.jmu_101_22

Integrative bioinformatics approach for identifying key genes and potential therapeutic targets in the concurrent manifestation of hypertrophic cardiomyopathy and pulmonary hypertension

Zheng, X., Zhang, C., Yang, T., Luo, Z., Xia, J., Tian, W., Shao, J., Zhang, H., Gong, J., & Bao, X. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1822

Abordagens atuais e perspectivas no diagnóstico da Cardiomiopatia Hipertrófica: desafios e avanços

Júnior, R. A. D. O. P., Lusvarghi, E. F. M., Garcia, G. M., Júnior, C. W. L. C., & Duarte, P. H. D. S. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n4-031

New Predictor of Ventricular Arrhythmia After Alcohol Septal Ablation: Preoperative Inferolateral Wall Thickness

Başkurt, A. A., Çolak, A., Kumral, Z., Yılancıoglu, R. Y., Dursun, H., Turan, O. E., Özpelit, E., Özcan, E. E., Badak, Ö., & Göldeli, Ö. (2024) · ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR · doi:10.36660/abcimg.20240013

Long road to success. Endocardial radiofrequency ablation of septal hypertrophy using three-dimensional electroanatomic mapping guided by echocardiography in a patient with hypertrophic obstructive cardiomyopathy and severe aortic stenosis

Zmudzińska, D., Ściborski, K., Szymkiewicz, P., Mak, M., Telichowski, A., Kustrzycka−Kratochwil, D., Doroszko, A., Banasiak, W., & Josiak, K. (2025) · Kardiologia Polska · doi:10.33963/v.phj.104190

KARDIOMIOPATI HIPERTROFI: SEBUAH TINJAUAN PUSTAKA

Nurhaliza, S., Hazaa, S. S., Rifa'i, A. N., Fadila, A., Nugraha, K. N., Syamsuddin, M. Z. M., Wenilia, R., Yahya, N. A., Putra, R. S. R., Kadarisma, S., et al. (2024) · Jurnal Kesehatan Tambusai · doi:10.31004/jkt.v5i4.36755

The Effect of Coronary Artery Disease on the Prognosis of Hypertrophic Cardiomyopathy: A Multi-Center Cohort Study

Liao, Q., Deng, X., Ma, H., Shu, Y., Zeng, S., Zhou, Y., Luo, L., Zhao, G., He, T., Liu, M., et al. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25045

A Clinical Study of Precision Chemoablation for Hypertrophic Obstructive Cardiomyopathy Without Large Interventricular Septal Branches

Cao, X., Huang, R., Geng, H.-H., Liu, H., Gu, Y., Xu, P., Chen, Y., Yao, J., & Sheng, H. (2025) · Clinical Cardiology · doi:10.1002/clc.70095

Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

牟, 妞. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153593

Correlation between left ventricular hypertrophy, myocardial fibrosis, and left atrial function in non-obstructive hypertrophic cardiomyopathy: insights from CMR-FT imaging

Zheng, Y., Ma, L., Wu, Q. V., Zhang, H., Li, Y., Li, R., & Zhu, L. (2025) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-025-03363-4

Phenotypic Variability of Cardiac Presentation in Danon Disease: Clinical Case Description

Romero, C. V. E., Fernandes, F., Mesquita, E. T., & Nunes, F. (2025) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20250002

Extreme left atrium dilatation in hypertrophic cardiomyopathy

Mangiameli, A., Monaco, M. L., Mollace, R., Bertella, E., Nardin, M., & Cao, D. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03931-5

Develop Program of Recreational Sport for Promoting Physical Fitness Among University Students in Fuzhou

Zhu, X., Chantasorn, N., & Kheovichai, K. (2025) · International Journal of Sociologies and Anthropologies Science Reviews · doi:10.60027/ijsasr.2025.5864

Praxis der Stressechokardiografie

Fehske, W., Kruck, S., ten Freyhaus, H., Korosoglou, G., & Voigt, J. (2025) · Kardiologie up2date · doi:10.1055/a-2321-7896

Investigating the Effects of High Intensity Exercise in a Preclinical Mouse Model of Hypertrophic Cardiomyopathy

Herrera, J. J. (2023) · Deep Blue (University of Michigan) · doi:10.7302/25536

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807

The Wait is Over: The 2020 American Heart Association/American College of Cardiology (AHA/ACC) Hypertrophic Cardiomyopathy Guidelines Have Arrived

Semsarian, C., & Davis, L. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.02.002 · Cited by 1

Hypertrophic cardiomyopathy: a practical approach to guideline directed management

Ommen, S. R., & Semsarian, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01205-8 · Cited by 92

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy

Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K., Evanovich, L., Ferrari, V. A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.014 · Cited by 425